Epstein Secrets

escent Plasma. In an op-ed for the New York Times <https://www.nytimes.corn/2020/09/02/opinion/coronavirus-convalescent-plasma.html> (9/2, 18.61M), Daniela J. Lamas, a critical care doctor, questions the Food and Drug Administration's "emergency use authorization for convalescent plasma despite inadequate eviden

ence." Along those lines, the Washington Post <https://www.washingtonpost.corn/health/2020/09/02/fda-coronavirus- vaccine-emergency-authority> (9/2, McGinley, Johnson, 14.2M) says "a fierce debate has erupted over whether the Food and Drug Administration should use its emergency authority to clear a coron

initive answer." Lamas: Insufficient Clinical Data For Efficacy Or Safety Of Convalescent Plasma. In an op-ed for the New York Times (9/2, 18.61M), Daniela J. Lamas, a critical care doctor, questions the Food and Drug Administration's "emergency use authorization for convalescent plasma despite inadequate evide

f the FDA and the CDC to urgently testify and answer questions about possible political interference." Along those lines, the Washington Post (9/2, McGinley, Johnson, 14.2M) says "a fierce debate has erupted over whether the Food and Drug Administration should use its emergency authority to clear a coro

initive answer." Lamas: Insufficient Clinical Data For Efficacy Or Safety Of Convalescent Plasma. In an op-ed for the New York Times (9/2, 18.61M), Daniela J. Lamas, a critical care doctor, questions the Food and Drug Administration's "emergency use authorization for convalescent plasma despite inadequate evide

f the FDA and the CDC to urgently testify and answer questions about possible political interference." Along those lines, the Washington Post (9/2, McGinley, Johnson, 14.2M) says "a fierce debate has erupted over whether the Food and Drug Administration should use its emergency authority to clear a coro